Industry News
Hunter Immunology agrees to Probiomics merger
The board and largest shareholders of Hunter Immunology have agreed to endorse a reverse takeover by Probiomics (ASX:PCC) to create a company with a $37.2m market cap. [ + ]
Prof Ian Frazer elected to Australian Academy of Science council
Professor Ian Frazer, who was named Australian of the Year in 2006 for his development of the human papillomavirus (HPV) cervical cancer vaccines, has become one of the most recent members of the Australian Academy of Science, alongside a Nobel Laureate, a Eureka prize winner and a pioneer in mathematics.
[ + ]Researchers in Sydney Blaze ahead with world-leading microscope technology
The world’s first system for studying the cell biology of living microorganisms at super-resolution has been installed at the University of Technology, Sydney, promising new insights into the behaviour of infectious diseases.
[ + ]BioDiem buys Savine Therapeutics
Vaccine company BioDiem (ASX:BDM) has added antigen development technology to its portfolio with the purchase of Savine Therapeutics. [ + ]
IQnovate completes public listing on NSX
Shares in contract medical services company IQnovate (NSX:IQN) start strong, but then pare some of their early gains, during the first day of public trading. [ + ]
UTS installs live super-resolution microscope
A super-resolution imaging system that can produce real-time footage of living cells has been installed in the University of Technology Sydney. [ + ]
Compumedics wins $1m EEG deal
Compumedics (ASX:CMP) has picked up a deal to supply an EEG system to the Yale School of Medicine. [ + ]
Government must do more to promote ethical standards in the promotion of health sector products: IVD Australia
IVD Australia has expressed disappointment that the Therapeutic Goods Administration's new blueprint on regulation of the promotion of therapeutic goods doesn't do enough to raise ethical standards in the industry. [ + ]
Phylogica partnership with Pfizer hits first milestone
Drug discovery company Phylogica (ASX:PYC) has received its first milestone payment from a collaboration with Pfizer to discover novel peptide-based vaccines. [ + ]
Researchers discover scalable stem cell production method for liver and pancreas precursor cells
Scientists in Canada have overcome a key research hurdle to developing regenerative treatments for diabetes and liver disease with a technique to produce medically useful amounts of endoderm cells from human pluripotent stem cells.
[ + ]Government about to release $1.2 billion cleantech program for manufacturers
Registrations of interest are open now for three components of the Government's soon-to-be-released $1.2 billion Clean Technology Program. [ + ]
Biomedica Gruppe appoints new distributor
United Bioresearch Products has been appointed as the Australian distributor for the Biomedica range of ELISA kits and antibodies. [ + ]
Greg Combet takes over as Minister for Innovation
A cabinet reshuffle has seen Greg Combet take over as Innovation Minister from Kim Carr, who has been demoted to the outer ministry. [ + ]
New appointment to CSIRO board
Professor Peter Høj, Vice Chancellor and President of the University of South Australia, has been appointed a part-time member to the CSIRO Board.
[ + ]DSM Biologics and AIBN partner to open biologics facility in Queensland
Dutch CMO DSM Biologics has signed a MoU with the Australian Institute for Bioengineering and Nanotechnology to open Australia’s largest biologics facility in Queensland. [ + ]

